TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.530
+0.030 (2.00%)
At close: Oct 17, 2025, 4:00 PM EDT
1.560
+0.030 (1.96%)
After-hours: Oct 17, 2025, 4:10 PM EDT
TELA Bio Market Cap
TELA Bio has a market cap or net worth of $60.61 million as of October 17, 2025. Its market cap has decreased by -0.30% in one year.
Market Cap
60.61M
Enterprise Value
68.78M
1-Year Change
-0.30%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since November 8, 2019, TELA Bio's market cap has decreased from $146.94M to $60.61M, a decrease of -58.75%. That is a compound annual growth rate of -13.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 60.61M | -49.04% |
| Dec 31, 2024 | 118.95M | -26.62% |
| Dec 29, 2023 | 162.12M | -26.42% |
| Dec 30, 2022 | 220.33M | 18.68% |
| Dec 31, 2021 | 185.65M | -14.47% |
| Dec 31, 2020 | 217.06M | 46.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |